March 31, 2026
Today — March 31, 2026 — marks a quiet inflection point in healthcare. As of this morning, every Medicare Advantage organization, Medicaid managed care plan, and Qualified Health Plan issuer on the federal exchange is required to publicly report their prior authorization metrics for calendar year 2025.
That means approval rates, denial rates, average decision turnaround times, and appeals outcomes are now visible to anyone with a browser. For the first time, the prior auth black box is cracked open.
If you run an ACO, MSO, or health system with Medicare exposure, this isn't a regulatory footnote — it's a strategic signal. Here's why.
Under the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F), impacted payers must publish aggregated prior authorization metrics on their public websites annually. The first reports — covering calendar year 2025 — are due today.
Required metrics include:
MA organizations report at the contract level. State Medicaid and CHIP programs report at the state level. Managed care plans report at the plan level.
One notable exclusion: drugs are carved out. Only medical items and services fall under this mandate.
On the surface, this is a transparency play. But underneath, it creates three dynamics that directly impact ACO operations:
For the first time, you can compare denial rates across payers in your market. If Payer A denies 30% of prior auth requests and Payer B denies 12%, that's not just interesting — it's actionable intelligence for contract negotiations, network decisions, and care routing.
With public data on which service categories get denied most frequently, your rev cycle and care management teams can build pre-submission denial risk models. You don't need to wait for a denial to react — you can anticipate it.
This transparency mandate is just the first shoe to drop. By January 2027, impacted payers must implement a FHIR-based Prior Authorization API that accepts and returns structured electronic prior auth requests. The infrastructure burden on payers is about to spike — and the operational ripple effects will hit providers.
While everyone is focused on transparency reporting, there's a parallel development that deserves more attention: the Wasteful and Inappropriate Service Reduction (WISeR) Model.
Launched January 1, 2026, WISeR is running in six states — Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. It uses AI and machine learning to screen prior authorization requests for select Medicare FFS services.
Here's what makes WISeR significant:
The six WISeR participants include Cohere Health, Innovaccer, Humata Health, Genzeon, Virtix Health, and Zyter. If you're an ACO in one of those six states, your claims are already being screened by AI. The question is whether your submission workflows are optimized for that reality.
The organizations that will benefit from this regulatory shift are the ones that treat it as an operational opportunity, not a compliance checkbox. Here's the playbook:
Pull the public prior auth reports from every payer in your network. Build a denial rate dashboard by payer and service category. Use it to prioritize which workflows to automate first — start with the highest-denial, highest-volume service lines.
If 61% of physicians believe AI is increasing payer denials (per the latest AMA survey), the answer isn't to fight AI with paper — it's to fight AI with better AI. Pre-submission risk models that flag high-denial-probability requests before they're sent give your team time to strengthen documentation, attach supporting evidence, or reroute the request.
The prior auth API requirement is 9 months away. Payers will be required to accept electronic prior auth requests via FHIR APIs. ACOs that integrate their EHR and care management workflows with these APIs early will see faster approvals, fewer manual touches, and lower administrative burden.
Your claims are being AI-screened today. Clean clinical documentation, accurate coding, and complete submissions aren't best practices anymore — they're requirements for getting paid on time. Purpose-built AI tools like ZynScribe that ensure documentation completeness at the point of care are no longer optional.
Here's what most analysis of the transparency rule misses: prior authorization is a symptom, not the disease.
The real problem is that most ACOs still run care management, documentation, and revenue cycle workflows on manual processes augmented by dashboards. They can see the problem — they just can't execute the fix at scale.
At Zynix AI, we built an AI operating system specifically for this execution gap. Our AI agents don't just flag prior auth risks — they execute the workflow: pulling the right clinical documentation, attaching it to the submission, routing to the right reviewer, and tracking the outcome. When PBACO deployed our platform, their care management team went from reactive denial management to proactive submission optimization — handling more volume with the same staff.
The transparency rule makes the problem visible. AI agents make it solvable.
The prior auth landscape is moving faster than most ACO leaders realize:
The ACOs that automate prior auth workflows now won't just reduce denials — they'll build a structural operational advantage that compounds over the next five years.
The data is public. The AI is already screening your claims. The question is whether your workflows are ready.